Commentaries on Jackson et al. "Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction"

Saved in:
Bibliographic Details
Published inJournal of sexual medicine Vol. 2; no. 5; p. 740
Main Authors Kloner, Robert A, Montorsi, Piero, DeBusk, Robert F
Format Journal Article
LanguageEnglish
Published Netherlands 01.09.2005
Subjects
3',5'-Cyclic-GMP Phosphodiesterases
Coronary Artery Disease - drug therapy
Coronary Artery Disease - epidemiology
Coronary Artery Disease - physiopathology
Cyclic Nucleotide Phosphodiesterases, Type 5
Erectile Dysfunction - epidemiology
Humans
Male
Nitro Compounds - administration & dosage
Nitro Compounds - therapeutic use
Phosphodiesterase Inhibitors - administration & dosage
Phosphodiesterase Inhibitors - therapeutic use
Phosphoric Diester Hydrolases - metabolism
Severity of Illness Index
Withholding Treatment
Online AccessGet more information

Cover

More Information
ISSN:1743-6095
DOI:10.1111/j.1743-6109.2005.00121.x